The recent finding that enrichment of peripheral CD8+PD1+ T cell associates with poor overall survival in a cohort of patients affected by metastatic cancer (≈50% HNSCC) and submitted to immune-checkpoint inhibitors [53] may be interpreted as a clinical consequence of the biologic phenomena highlighted by our data. Here, CD8A is linked to head and neck squamous cell carcinoma.